NASDAQ · ATPCHealthcareHealth Services

Agape ATP Corporation Common Stock (ATPC)

$1.49+14.62%
Close Nov 4, 2026 · split-adjusted
Oct 30, 2026$1.45▼ 97.60% in range
Nov 3, 2025Low $1.37 · High $69.00Oct 30, 2026
What changed · written from our data
As of Nov 4, 2026

Agape ATP closed at $1.49 on Nov 4, up 14.62%, 97.8% below its 52-week closing high. Volume of 131.5K shares was 2.55× its 20-day average (well above normal).

Split-adjusted performance: -28.4% over one month, -45.2% over six months.

In the quarter ended Jun 30, 2026, revenue was $13.69K, down 93.4% from a year earlier, with a net margin of 1117.4%.

Short interest was 7.0K shares at the Oct 15 settlement, down 28.7% from the prior report (0.7% of float, 1.0 days to cover).

Market cap$1.5M1.0M shares
Revenue · quarter$13.7K−93.4% YoY
Diluted EPS$0.15—
P/E · TTM—P/S 1.4×
Net margin1,117.4%Gross 86.0%
Dividend yieldNone
52-week range1.30 – 69.00−97.8% from high
Volume131.5K2.55× 20-day avg
Volatility · 60d66.5%Annualised
Short % of float0.7%1.0 days to cover
Net cash-$2.0KCash $45.5K
Next earnings—Not scheduled
Split-adjusted performance
1W −2.6%1M −28.4%3M −40.2%6M −45.2%YTD −72.0%1Y —3Y −99.8%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Health Services

Percentile among 20 companies (100 = best)

6-month momentum11
Revenue growth0
Net margin100
Value (low P/E)—
Size0

Industry medians: 6-month return +21.3%, revenue growth +7.8%, net margin 3.0%, P/E 74.7×.

Short interest

Details →
Shares short7.0K−28.7% vs prior
Days to cover1.0Settled Oct 15
% of float0.7%
Short vol. 10d42.0%of daily volume

Closest peers by size in Health Services

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
ATPCAgape ATP$1.49+14.62%−45.2%−93.4%1117.4%—$1.5M
BRTXBioRestorative Therapies, Inc. Common Stock (NV)$1.51+2.03%−69.2%−7.3%−9298.3%—$2.1MCompare
MGRXMangoceuticals$0.2071−5.00%−41.0%−37.9%−5447.9%—$4.6MCompare
PIIIP3 Health Partners$4.10+6.77%+43.4%+8.6%−0.6%—$16.0MCompare
DCGODocGo$0.2606+2.88%−58.1%−8.7%−21.5%—$25.8MCompare
CCELCryo-Cell International$5.07+0.40%+43.6%0.0%16.2%—$40.9MCompare
EUDAEUDA Health Holdings Limited$16.00+0.57%+21.5%———$47.9MCompare
PARKPark Dental Partners$21.35+5.15%+22.5%—2.0%—$101.5MCompare
VMDViemed Healthcare$10.11+6.93%+18.7%+23.9%3.5%26.6$385.1MCompare

News about Agape ATP

All news →

No recent articles focused on Agape ATP.

Quick answers

What does Agape ATP do?
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs.
What is ATPC's market cap?
$1.49M, based on the Nov 4 close of $1.49.
Does Agape ATP pay a dividend?
No regular cash dividend has been paid in the last year.
How much of ATPC is sold short?
7.0K shares, 0.7% of float, as of Oct 15, 2026.
What sector is ATPC in?
Healthcare, in the Health Services industry.

About Agape ATP

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.

HQ: Kuala Lumpur, N818 employeesListed Sep 17, 2018agapeatp.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology